This HTML5 document contains 111 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://dx.doi.org/10.1038/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q88004130
rdf:type
wikibase:Item
schema:description
scientific article published on 02 June 2014 wetenschappelijk artikel наукова стаття, опублікована в червні 2014 artículu científicu espublizáu en xunu de 2014
p:P577
wds:Q88004130-ADD9E89C-423E-4533-95B8-212846F6506F
wdt:P577
2014-06-02T00:00:00Z
p:P2860
wds:Q88004130-6676C9CC-0E32-45A6-9EA6-B426C0EBCCD7 wds:Q88004130-6EFE7A97-2782-4E0D-A20C-E6EE9A74A08E wds:Q88004130-8479C3CB-DF8D-49BE-BB81-3B6632C54943 wds:Q88004130-8A91430B-FB88-453A-8436-8C5D2AF88F8F wds:Q88004130-92EF7B3E-0FC5-4AA5-9B31-D63023EAD3E4 wds:Q88004130-9C46E2A1-0DD9-4039-9E56-294190C14CE0 wds:Q88004130-959B6E73-88E2-4500-80C2-46203E99B1A3 wds:Q88004130-A789BF4F-2768-40ED-B590-74CCC3275AEC wds:Q88004130-A7091144-D76F-4A48-A6F0-E036ED95947C wds:Q88004130-A8949720-D1C4-48CD-913A-3EA97FB0BEC6 wds:Q88004130-B3CF201F-0623-4990-AEEE-1E662CEBD1BE wds:Q88004130-AEB83CC0-C105-4446-B37C-346E6CBB9A33 wds:Q88004130-E151D885-4A9C-4B58-982A-BF47482929EC wds:Q88004130-E44ADE6C-6AA3-4864-9FF3-D8A60F565845 wds:Q88004130-E32B6490-F9EA-4874-BB80-BDCE20A206EA wds:Q88004130-E5C026FF-596F-4145-8033-188A297866D1 wds:Q88004130-FCBE9DD9-A339-46A5-9CA3-93DA99B81E3E wds:Q88004130-F88F9415-A206-44C8-A094-70AE1F40052F wds:Q88004130-01CBD78F-5EBD-43DC-8741-D41D178E4FB0 wds:Q88004130-08D34D64-BCBB-4253-9977-B5CE39763E4B wds:Q88004130-02641B34-EC85-4582-9D0D-9E87F8A5F00A wds:Q88004130-09898A12-F7DE-4498-9ECF-1A5AE2A10558 wds:Q88004130-1EC2F1D6-CFCF-4EE4-B064-931A07C6B595 wds:Q88004130-280139B9-5091-46F3-921E-A5258B2960DD wds:Q88004130-2E843B77-CA69-464C-8687-A28B3BCBC263 wds:Q88004130-2E309730-7F90-42BA-B4F0-9244466C0397 wds:Q88004130-404BF335-3526-426C-862F-82C6320E6346 wds:Q88004130-3FA50F52-C7F4-4626-BC01-7539F871AF63 wds:Q88004130-47786FDC-F00E-4D5F-AA9B-AB42815B4C89
wdt:P2860
wd:Q43282877 wd:Q44913254 wd:Q82400928 wd:Q73370268 wd:Q40735730 wd:Q46837561 wd:Q34412254 wd:Q45960012 wd:Q73181409 wd:Q34418466 wd:Q71531817 wd:Q37234638 wd:Q36256854 wd:Q83171376 wd:Q51405815 wd:Q45861930 wd:Q46052750 wd:Q40426422 wd:Q51680781 wd:Q36579055 wd:Q43459178 wd:Q37082345 wd:Q35794832 wd:Q51705517 wd:Q40622437 wd:Q80170711 wd:Q46009370 wd:Q80975625 wd:Q81796264
p:P2093
wds:Q88004130-0EB045A4-691E-41BB-B386-185EEEFB50C5 wds:Q88004130-0E6B9999-DA49-478A-B062-DF2A3FDD93FF wds:Q88004130-09AD3F31-15E6-412E-94C0-5244B5812531 wds:Q88004130-4131407A-C84E-4ED5-93E3-9234E878A4F9 wds:Q88004130-40C7C377-6C2B-4C1C-AD2C-1DAB6D59993F wds:Q88004130-F146B98A-29AC-4C87-8231-D1F3658940D9 wds:Q88004130-8EEA62F9-AC03-4F26-B22F-7912B8848A47 wds:Q88004130-6882AF9E-E171-467C-9BF5-BCDBDE50286C
wdt:P2093
K E Herbert J F Seymour L Demosthenous H M Prince N Came D A Westerman E Link D S Ritchie
rdfs:label
Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial
skos:prefLabel
Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial
schema:name
Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial
p:P50
wds:Q88004130-09F5E5EF-CE66-450F-9578-78561CDE9FC2 wds:Q88004130-004D1317-DB53-48B8-8652-0E16394AEB88
wdt:P50
wd:Q47348076 wd:Q56459492
p:P1476
wds:Q88004130-01196820-0447-4F41-9737-357C9DB1271A
wdt:P1476
Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial
p:P304
wds:Q88004130-2159455A-E6C5-414E-AFC6-FB26F2CD264B
wdt:P304
1056-1062
p:P31
wds:Q88004130-BDBBBF13-EF2F-4499-85CD-D82A6259C81C
wdt:P31
wd:Q13442814
p:P921
wds:Q88004130-744A1BE9-2E3B-41C5-9DC6-71D9DDACB23C
wdt:P921
wd:Q5452194
p:P698
wds:Q88004130-F0145184-310D-4889-97A2-2CBE48BB0525
wdtn:P698
n11:24887382
wdt:P698
24887382
p:P1433
wds:Q88004130-F1D7DB5B-02CC-4B3A-8EFC-9104521FCEDE
wdt:P1433
wd:Q4941523
p:P433
wds:Q88004130-942F5EE6-3C1F-4BEE-96FF-30C783B0FD46
p:P478
wds:Q88004130-58C6EDE3-5813-48DA-A4BE-35DDD1B57D0A
wdt:P433
8
wdt:P478
49
p:P356
wds:Q88004130-7DD0948F-03D0-4C92-8C36-35D941A717BA
wdtn:P356
n5:BMT.2014.112
wdt:P356
10.1038/BMT.2014.112